SC
VYGR icon

Steven Cohen’s Voyager Therapeutics VYGR Stock Holding History

Steven Cohen’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$826K Sell
236,083
-32,140
-12% -$122K ﹤0.01% 2936
2026
Q1 		$1.04M Buy
268,223
+172,872
+181% +$681K ﹤0.01% 2743
2025
Q4 		$375K Buy
+95,351
New +$422K ﹤0.01% 3380
2025
Q1 		– Sell
-1,182
Closed -$6.7K – 2584
2024
Q4 		$6.7K Buy
+1,182
New +$7.62K ﹤0.01% 2032
2023
Q2 		– Sell
-6,224
Closed -$48K – 2832
2023
Q1 		$48K Buy
+6,224
New +$49.5K ﹤0.01% 1792
2022
Q4 		– Sell
-289,420
Closed -$1.71M – 1814
2022
Q3 		$1.71M Buy
+289,420
New +$1.85M 0.01% 952
2018
Q4 		– Sell
-101,975
Closed -$1.93M – 1227
2018
Q3 		$1.93M Buy
+101,975
New +$1.96M 0.01% 768
2017
Q4 		– Sell
-130,900
Closed -$2.69M – 1095
2017
Q3 		$2.69M Buy
+130,900
New +$1.48M 0.01% 637

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Steven Cohen's VYGR Position: Q2 2026 in Review

Steven Cohen reduced its Voyager Therapeutics (VYGR) stake by 12% in Q2 2026, selling an estimated $122K and leaving 236,083 shares worth $826K. The position accounts for ﹤0.01% of the portfolio, ranked #2936.

Steven Cohen first reported a position in VYGR in Q3 2017 and has held it in 8 quarters since. The position peaked at $2.69M in Q3 2017. 135 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Steven Cohen held 236,083 shares of Voyager Therapeutics worth $826K as of Q2 2026.
  • Steven Cohen sold 32,140 Voyager Therapeutics shares in Q2 2026, an estimated $122K.
  • Voyager Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #2936 holding.
  • Steven Cohen first reported a position in Voyager Therapeutics in Q3 2017 and has held it in 8 quarters since.
  • Steven Cohen's Voyager Therapeutics position peaked at $2.69M in Q3 2017.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.